PDS Biotechnology Corpora...
(PDSB)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 57.33K | 49.08K | 246.39K | 176.29K | 98.41K | 69.12K | 182.92K | 100.12K | 53.12K | - | - |
Gross Profit | -57.33K | -49.08K | -246.39K | -176.29K | -98.41K | -69.12K | -182.92K | -100.12K | -53.12K | - | - |
Operating Income | -43.05M | -41.67M | -21.44M | -14.90M | -21.03M | -43.10M | -51.97M | -39.51M | -26.50M | -13.19M | -6.49M |
Interest Income | 2.90M | 935.18K | 4.35K | 55.01K | 353.49K | 871.88K | 700.90K | 212.30K | 9.08K | 2.94K | 3.95K |
Pretax Income | -44.35M | -42.05M | -21.43M | -14.85M | -7.38M | -43.65M | -53.45M | -40.67M | -29.19M | -12.79M | -7.34M |
Net Income | -42.94M | -40.85M | -16.92M | -14.85M | -7.00M | -40.87M | -50.86M | -38.82M | -28.08M | -12.20M | -6.88M |
Selling & General & Admin | 15.28M | 12.24M | 10.18M | 6.96M | 10.98M | 14.29M | 17.65M | 14.69M | 8.66M | 4.72M | 2.00M |
Research & Development | 27.76M | 29.43M | 11.25M | 7.92M | 6.10M | 16.07M | 34.31M | 24.83M | 17.84M | 8.47M | 4.48M |
Other Expenses | 0.00 | - | - | 15.61K | 3.95B | 12.74B | - | -163.46K | -1.88M | - | - |
Operating Expenses | 43.05M | 41.67M | 21.44M | 14.90M | 17.08M | 30.36M | 51.97M | 39.51M | 26.50M | 13.19M | 6.49M |
Interest Expense | 4.21M | 1.32M | - | - | 33.56K | 1.43M | 2.18M | 1.20M | 816.49K | 183.18K | 3.35K |
Selling & Marketing Expenses | 264.00K | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 43.05M | 41.67M | 21.44M | 14.90M | 17.08M | 30.36M | 51.97M | 39.51M | 26.50M | 13.19M | 6.49M |
Income Tax | -1.41M | -1.20M | -4.52M | -135.68K | -381.51K | -2.78M | -2.59M | -1.85M | -1.11M | -590.67K | -459.02K |
Shares Outstanding (Basic) | 30.95M | 28.60M | 25.60M | 16.75M | 4.87M | 1.56M | 1.52M | 1.44M | 404.40K | 755.36K | 755.36K |
Shares Outstanding (Diluted) | 30.95M | 28.60M | 25.60M | 16.75M | 4.87M | 1.56M | 1.52M | 1.44M | 404.40K | 755.36K | 755.36K |
EPS (Basic) | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 | -26.16 | -33.47 | -26.9 | -69.43 | -16.15 | -9.11 |
EPS (Diluted) | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 | -26.16 | -33.47 | -26.9 | -69.43 | -16.15 | -9.11 |
EBITDA | -40.08M | -41.62M | -21.19M | -14.67M | -7.25M | -3.58M | -51.08M | -39.36M | -28.32M | -13.16M | -6.48M |
Depreciation & Amortization | 57.33K | 49.08K | 246.39K | 176.29K | 98.41K | 69.12K | 182.92K | 100.12K | 53.12K | 31.23K | 4.44K |